Stefan Prendergast
Our team

Stefan Prendergast

Research Analyst

Stefan conducts scientific and commercial analysis of medical technology assets. Before joining RTW, Stefan was a life sciences consultant at L.E.K.

Consulting in London and New York where he led strategic engagements for medtech, biopharmaceutical, and healthcare clients as well as leading investment firms. At L.E.K., his project experience encompassed commercial opportunity assessments, M&A advisory, innovation and growth strategy, and R&D portfolio prioritization.

In the rapidly evolving healthcare landscape that is grounded in the concept of continual discovery and innovation, I feel invigorated to be a part of a world-class team at RTW that seeks to identify, support, and accelerate step-change medical advancements. RTW’s mission enables value to be delivered to all stakeholders, most importantly patients.

Stefan holds an MSc in Biochemistry and Molecular Biology with a focus on cancer biology from Johns Hopkins Bloomberg School of Public Health and a BS in Biological Sciences from the University of Notre Dame.